Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a -14.105% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a: Cc1ccc(N(CC(=O)NCc2ccco2)C(=O)CCC(=O)Nc2nccs2)cc1C
b: COc1ccccc1CNC(=O)C1CCC(CNc2c(N3CCOCC3)c(=O)c2=O)CC1
c: O=C(CSc1nc2ccccc2c(=O)n1CC1CCCO1)Nc1ccccc1
Answer: c. O=C(CSc1nc2ccccc2c(=O)n1CC1CCCO1)Nc1ccccc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=C(CSc1nc2ccccc2c(=O)n1CC1CCCO1)Nc1ccccc1
O=C(CSc1nc2ccccc2c(=O)n1CC1CCCO1)Nc1ccccc1
2-[4-oxo-3-(oxolan-2-ylmethyl)quinazolin-2-yl]sulfanyl-N-phenylacetamide